Sarepta Therapeutics (SRPT) Insider Trading & Ownership

→ SHOCKING Crypto Leak… (From Crypto 101 Media) (Ad)

$115.62

-0.93 (-0.80%)

(As of 04/19/2024 ET)

Current Insider Ownership Percentage: 7.40%
Number Of Insiders Buying (Last 12 Months): 3
Amount Of Insider Buying (Last 12 Months): $10.74 M
Number Of Insiders Selling (Last 12 Months): 5
Amount Of Insider Selling (Last 12 Months): $4.34 M

Get SRPT Insider Trade Alerts

Want to know when executives and insiders are buying or selling Sarepta Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SRPT Insider Buying and Selling by Quarter

Ad DTI

Biden’s $374B Giveaway Into This Sector

Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here

Click here for the full story

Sarepta Therapeutics Insider and Congressional Trades History

Transaction Type

Time Frame

Start Date

End Date

Export to Excel

Transaction Date	Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction
3/11/2024	Kathryn Jean Boor	Director	Sell	761	$122.93	$93,549.73
3/8/2024	Hans Lennart Rudolf Wigzell	Director	Sell	15,000	$123.25	$1,848,750.00
3/5/2024	Stephen Mayo	Director	Sell	3,135	$122.96	$385,479.60
3/1/2024	Bilal Arif	Insider	Sell	2,000	$128.84	$257,680.00
3/1/2024	Ian Michael Estepan	CFO	Sell	1,200	$128.30	$153,960.00
11/3/2023	Douglas S Ingram	CEO	Buy	25,225	$79.36	$2,001,856.00
Get Insider Trades Delivered To Your Inbox Enter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings.
11/3/2023	Richard Barry	Director	Buy	50,000	$78.81	$3,940,500.00
8/14/2023	Michael Andrew Chambers	Director	Buy	9,979	$109.47	$1,092,401.13
8/10/2023	Michael Andrew Chambers	Director	Buy	34,867	$106.15	$3,701,132.05
8/4/2023	Hans Lennart Rudolf Wigzell	Director	Sell	15,000	$106.72	$1,600,800.00

(Data available from 1/1/2013 forward)

SRPT Insider Trading Activity - Frequently Asked Questions

Who is on Sarepta Therapeutics's Insider Roster?: The list of insiders at Sarepta Therapeutics includes Bilal Arif, Douglas S Ingram, Hans Lennart Rudolf Wigzell, Ian Michael Estepan, Kathryn Jean Boor, Louise Rodino-Klapac, Michael Andrew Chambers, Richard Barry, and Stephen Mayo. Learn more on insiders at SRPT.
What percentage of Sarepta Therapeutics stock is owned by insiders?: 7.40% of Sarepta Therapeutics stock is owned by insiders. Learn more on SRPT's insider holdings.
Which Sarepta Therapeutics insiders have been buying company stock?: The following insiders have purchased SRPT shares in the last 24 months: Douglas S Ingram ($2,001,856.00), Michael Andrew Chambers ($15,755,773.78), and Richard Barry ($3,940,500.00).
How much insider buying is happening at Sarepta Therapeutics?: Insiders have purchased a total of 223,341 SRPT shares in the last 24 months for a total of $21,698,129.78 bought.

Which Sarepta Therapeutics insiders have been selling company stock?: The following insiders have sold SRPT shares in the last 24 months: Bilal Arif ($257,680.00), Hans Lennart Rudolf Wigzell ($3,449,550.00), Ian Michael Estepan ($153,960.00), Kathryn Jean Boor ($93,549.73), and Stephen Mayo ($479,790.96).
How much insider selling is happening at Sarepta Therapeutics?: Insiders have sold a total of 37,954 Sarepta Therapeutics shares in the last 24 months for a total of $4,434,530.69 sold.
Which members of congress are trading Sarepta Therapeutics?: Josh Gottheimer (D-NJ) has bought shares of Sarepta Therapeutics in the last year totaling $8,000. Josh Gottheimer (D-NJ) has sold shares totaling $8,000.

More Insider Trading Tools from MarketBeat

Related Companies:

Insider Tracking Tools:

Insider Trading By Country:

Latest Articles:

This page (NASDAQ:SRPT) was last updated on 4/20/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Sarepta Therapeutics (SRPT) Insider Trading & Ownership

SRPT Insider Buying and Selling by Quarter

Sarepta Therapeutics Insider and Congressional Trades History

SRPT Insider Trading Activity - Frequently Asked Questions

More Insider Trading Tools from MarketBeat

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Sarepta Therapeutics (SRPT) Insider Trading & Ownership

Sarepta Therapeutics (NASDAQ:SRPT) Insider Buying and Selling Activity

SRPT Insider Buying and Selling by Quarter

Sarepta Therapeutics Insider and Congressional Trades History

SRPT Insider Trading Activity - Frequently Asked Questions

More Insider Trading Tools from MarketBeat